Inhibitors in Hemophilia: A Primer – Traditional Chinese

Also Available In: English, Spanish This is not an official WFH translation. This resource has been translated with permission by a WFH National Member Organization (NMO), and is shared here with their kind permission. Translating organizations are encouraged to have translations reviewed by local experts, the WFH is not responsible for the translation or for […]

Penser les inhibiteurs différemment | Sommet virtuel 2020

La principale complication du traitement et de la prévention des hémorragies est le développement d’anticorps inhibiteurs contre le facteur VIII thérapeutique (FVIII). On constate cette réaction adverse chez près de 40% des personnes atteintes d’hémophilie A sévère (HA). Les raisons pour lesquelles certaines personnes atteintes d’HA développent des inhibiteurs tandis que d’autres non, ne sont […]

Inhibitors – Think differently | Virtual Summit 2020 – Russian

The development of inhibitory antibodies to therapeutic factor VIII (FVIII) in up to 40% of people with severe hemophilia A (HA) is the major complication in treatment/prevention of hemorrhages. The reasons some people with HA develop inhibitors while others do not, remain unclear. In this session from the WFH 2020 Virtual Summit, Sebastien Lacroix-Desmazes, Kathleen […]

Inhibitors – Think differently | Virtual Summit 2020

The development of inhibitory antibodies to therapeutic factor VIII (FVIII) in up to 40% of people with severe hemophilia A (HA) is the major complication in treatment/prevention of hemorrhages. The reasons some people with HA develop inhibitors while others do not, remain unclear. In this session from the WFH 2020 Virtual Summit, Sebastien Lacroix-Desmazes, Kathleen […]

Inhibidores – pensar diferente | Cumbre virtual 2020

El desarrollo de anticuerpos inhibidores del factor VIII terapéutico (FVIII) en hasta el 40% de las personas con hemofilia A grave (HA) es la principal complicación en el tratamiento o prevención de hemorragias. Las razones por las que algunas personas con HA desarrollan inhibidores mientras que otros no, no son claras. En esta sesión de […]

Los Inhibidores en la Hemofilia: información básica

This resource has also been translated into the following languages, with permission from the WFH, by NMOs: Traditional Chinese Los inhibidores constituyen una complicación grave de la hemofilia causados por una respuesta inmunológica a los concentrados de factor de coagulación. El tratamiento de los inhibidores es uno de los mayores desafíos de la atención de […]

What is Hemophilia?

Also Available In: Japanese This resource has also been translated into the following language, with permission from the WFH, by NMOs: Amharic, Setswana This patient handbook contains basic information about the inheritance, symptoms, and management of hemophilia.

Inhibitors in Hemophilia: A Primer

This resource has also been translated into the following languages, with permission from the WFH, by NMOs: Traditional Chinese Inhibitors are a serious complication of hemophilia caused by an immune response to clotting factor concentrates. Treatment of inhibitors is one of the biggest challenges in hemophilia care today. This primer explains our current understanding of […]

Porcine Factor VIII

In the Monday afternoon session on alternative therapies in the management of inhibitors, Rebecca Kruse-Jarres discusses the latest developments in the use of porcine factor VIII.